T. Cerny
Impact in
-
- Chemotherapy-induced organ toxicity mitigation
- Lymphoma Diagnosis and Treatment
- Oncology top 10%
- Drug Transport and Resistance Mechanisms
- Cancer Treatment and Pharmacology
Papers in
-
- Chemotherapy-induced organ toxicity mitigation 11
- Oncology 13
- Cancer Treatment and Pharmacology 4
- Drug Transport and Resistance Mechanisms 3
- Lung Cancer Research Studies 3
- Co-authors
- A Küpfer (8 shared papers)C. Aeschlimann (2 shared papers)Martin F. Fey (6 shared papers)J. Margison (3 shared papers)Michael Lind (2 shared papers)B H Lauterburg (2 shared papers)N. Thatcher (3 shared papers)Cristiana Sessa (7 shared papers)
- Journals
- Annals of Oncology (6 papers)British Journal of Cancer (3 papers)Journal of Cancer Research and Clinical Oncology (3 papers)Cancer Chemotherapy and Pharmacology (2 papers)Journal of Clinical Oncology (1 paper)
- Partner nations
- SwitzerlandUnited KingdomItaly
In The Last Decade
T. Cerny
36 papers receiving 856 citations
Peers
Comparison fields: 5 of 89
- Pathology and Forensic Medicine 311
- Oncology 285
- Genetics 100
- Hematology 75
- Pharmacology 45
Countries citing papers authored by T. Cerny
This map shows the geographic impact of T. Cerny's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. Cerny with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. Cerny more than expected).
Fields of papers citing papers by T. Cerny
This network shows the impact of papers produced by T. Cerny. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. Cerny. The network helps show where T. Cerny may publish in the future.
Co-authors
The 25 scholars most cited alongside T. Cerny, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1994 | 133 | |
| 2 | 1996 | 88 | |
| 3 | Assessment of P-glycoprotein, glutathione-based detoxifying enzymes and O6-alkylguanine-DNA alkyltransferase as potential indicators of constitutive drug resistance in human colorectal tumors. | 1991 | 81 |
| 4 | 1989 | 55 | |
| 5 | 2012 | 51 | |
| 6 | 1991 | 39 | |
| 7 | Thiodiglycolic acid is excreted by humans receiving ifosfamide and inhibits mitochondrial function in rats. | 1998 | 38 |
| 8 | 1997 | 37 | |
| 9 | 1989 | 32 | |
| 10 | 1999 | 30 | |
| 11 | 1993 | 26 | |
| 12 | 1986 | 25 | |
| 13 | 1998 | 24 | |
| 14 | 1988 | 24 | |
| 15 | 1995 | 23 | |
| 16 | 2006 | 23 | |
| 17 | 1998 | 21 | |
| 18 | 1991 | 20 | |
| 19 | Relationships among cell survival, O6-alkylguanine-DNA alkyltransferase activity, and reactivation of methylated adenovirus 5 and herpes simplex virus type 1 in human melanoma cell lines. | 1989 | 16 |
| 20 | 1995 | 15 |
About T. Cerny
T. Cerny is a scholar working on Pathology and Forensic Medicine, Oncology, Molecular Biology, Genetics and Pulmonary and Respiratory Medicine, having authored 36 papers that have together received 878 indexed citations. Recurring topics across this work include Chemotherapy-induced organ toxicity mitigation (11 papers), Cancer Treatment and Pharmacology (4 papers), Chronic Lymphocytic Leukemia Research (4 papers), Drug Transport and Resistance Mechanisms (3 papers), Lung Cancer Research Studies (3 papers), Renal and related cancers (2 papers), Electrolyte and hormonal disorders (2 papers) and Acute Lymphoblastic Leukemia research (2 papers). The work is most often cited by research in Pathology and Forensic Medicine (311 citations), Oncology (285 citations), Genetics (100 citations), Hematology (75 citations) and Pharmacology (45 citations). T. Cerny has collaborated with scholars based in Switzerland, United Kingdom and Italy. Frequent co-authors include A Küpfer, C. Aeschlimann, Martin F. Fey, J. Margison, Michael Lind, B H Lauterburg, N. Thatcher, Cristiana Sessa, Franziska Joncourt and P. M. Wilkinson. Their work appears in journals such as Annals of Oncology, British Journal of Cancer, Journal of Cancer Research and Clinical Oncology, Cancer Chemotherapy and Pharmacology and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.